NCT04634968 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

de Gee EA, Verdurmen JE, Bransen E, de Jonge JM, Schippers GM
A randomized controlled trial of a brief motivational enhancement for non-treatment-seeking adolescent cannabis users. J Subst Abuse Treat. 2014 Sep;47(3):181-8. doi: 10.1016/j.jsat.2014.05.00
Padwa H, Guerrero EG, Serret V, Rico M, Gelberg L
Adapting substance use brief interventions for adolescents: perspectives of adolescents living with adults in substance use disorder treatment. Subst Abuse Rehabil. 2018 Dec 5;9:137-142. doi: 10.2147/SAR.
Saunders B, Wilkinson C, Phillips M
The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction. 1995 Mar;90(3):415-24.

The Effectiveness of a Brief Motivational Interviewing (MI) Communication Via Instant Massaging on the Reduction of Drug Abuse Among Adolescents in Hong Kong: a Pilot Randomized Controlled Trial

Details for clinical trial NCT04634968

Clinical trial NCT04634968 - References